Use of interleukin-2 (IL-2) receptor-specific agents to treat al

Details Use of interleukin-2 (IL-2) receptor-specific agents to treat al Use of interleukin-2 (IL-2) receptor-specific agents to treat al

1996-12-11

1999-06-29

Fitzgerald, David L.

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Monoclonal antibody or fragment thereof

4241821, 4241831, 424 851, 424 852, 4241431, 4241451, 4241731, 42419711, 42419511, 4241541, 514 2, 514 8, A61K 39395, A61K 3820

Patent

active

059165596

ABSTRACT:
A method of lysing unwanted, non-malignant cells in a mammal, the cells having on their surfaces a receptor for a growth factor, and the method including administering to the mammal a cell-lysing amount of a substance characterized in that it has specific affinity for the receptor of the growth factor and has the ability to effect the lysis of the cells.

REFERENCES:
patent: 520226 (1894-05-01), Neville et al.
patent: 4359457 (1982-11-01), Neville et al.
patent: 4388309 (1983-06-01), Fabricius
patent: 4440747 (1984-04-01), Neville
patent: 4443427 (1984-04-01), Reinherz et al.
patent: 4489710 (1984-12-01), Spitler
patent: 4545985 (1985-10-01), Pastan
patent: 4550086 (1985-10-01), Reinherz et al.
patent: 4675382 (1987-06-01), Murphy
patent: 4677061 (1987-06-01), Rose et al.
patent: 4908433 (1990-03-01), Mertelsmann
patent: 4946674 (1990-08-01), von Eichborn et al.
patent: 5011684 (1991-04-01), Strom
patent: 5336489 (1994-08-01), Strom
patent: 5510105 (1996-04-01), Strom
patent: 5587162 (1996-12-01), Strom
patent: 5607675 (1997-03-01), Strom
patent: 5674494 (1997-10-01), Strom
Depper, et al. (1983) J. Immunol. 131(2):690.
Kirkman, et al. (1995) J. Exp. Med. 162(1):358-62.
Kirkman, et al. (1985) Fed. Proc. 44(4):1681, abst. No. 7430.
Strom, T., et al. (1985) Clin. Res. 33(2):561A.
Strom, T., et al. (1985) Kidney Int.
Kupiec--Weglinski, et al. (1985) Fed. Proc. 44(6): 1881, abst. No. 8589.
Depper et al., J. Cell. Biochem. 13th Annual UCLA Symposium, Abstract No. 0732 (1984).
Depper et al., Lyphokines 9:127-152 (1984).
Depper et al., Clinical Research 32(2) National Meeting, May 4-7, 1984.
Depper et al., Proc. Natl. Acad. Sci. USA 82:4230-4234 (1985).
Depper et al., J. Immunol. 132(6):3054-3061 (1984).
Duke, et al., Lymphokine Research 5(4):289-299 (1986).
Fitzgerald, et al., J. Clin. Invest. 74:966-971 (1984).
Fitzgerald et al., J. Cell. Biol. 97(5)(2):Abstract No. 1630, The American Society for Cell Biology 23rd Annual Meeting (1983).
Gillis, et al., J. Immunol. 120(6):2027-2032 (1978).
Greene et al., Fed. Proc. 39(3)(1):Abstract No. 1615, 64th Annual Meeting, Anaheim, CA (1980).
Greene et al., Cancer Research 45:4563s-4567s (1985).
Greene et al., Proceedings of a Symposium presented at the University of South California, Nov. 16-17, 1984.
Greene et al., Haematology and Blood Transfusion 29:388-395 (1985).
Greene et al., Clinical Research 33(2) National Meeting, May 3-6 (1985).
Hakimi, et al., J. Immunol. 147:1352-1359 (1991).
Junghans, et al., Cancer Research 50:1495-1502 (1990).
Korsmeyer, et al., Transplantation 33(2):184-190 (1982).
Korsmeyer, et al., Proc. Natl. Acad. Sci. USA 80:4522-4526 (1983).
Kronke, et al., Clinical Research 32(2):Abstract No. 418A (1984).
Leonard et al., Receptors and Recognition Series B, 17:45-66 (1984).
Leonard et al., Proc. Natl. Acad. Sci. USA 80:6957-6961 (1983).
Leonard et al., Fed. Proc. 44(3):Abstract No. 2212, 69th Annual, Anaheim, CA Apr. 21-26, 1985.
Leonard et al., Nature 311:626-631 (1984).
Leonard et al., Clinical Research 30(2) 1982.
Queen, et al., Proc. Natl. Acad. Sci. USA 86:10029-10033 (1989).
Rolfman, et al., Eur. J. Immunol. 17:701-706 (1987).
Schlick et al., Immunobiology 170 (1/2):1-122 (1985).
Smith, Ann. Rev. Immunol. 2:319-333 (1984).
Stock, et al., Transplantation Proceedings 28(2):915-916 (1996).
Tinubu et al., J. Immunol. 4330-4338 (1994).
Uchiyama, et al., J. Immunol. 126(4):1398-1430 (1981).
Uchiyama, et al., Transactions of the Association of American Physicians, 93rd Session, May 10-12 (1980).
Vincenti, et al., Transplantation 63(1):33-38 (1997).
Waldmann, et al., J. Exper. Med. 160:1450-1466 (1984).
Waldmann, et al., Proceedings of the 15th Int'l Symposium of The Princess Takamatsu Cancer Research Fund, Tokyo (1984).
Waldmann, et al., Birth Defects 19(3):31-36.
Walmann, Novel Interleukin 2 Receptor and Applications Thereof--Department of Helath and Human Service, Washington, D.C. (1987).
Anti-T-Cell Reagents for Human Bone Marrow Transplantation: Ricin Linked to Three Monoclonal Antibodies, Science 222:512-515.
Greene et al., J. Cell. Sci. Supp. 3:97-106 (1985).
Anasetti et al., Blood 84(4):1320-1327 (1994).
Billing et al., Hybridoma 1:303-311 (1982).
Brown et al., Proc. Natl. Acad. Sci. 68:2663-2667 (1991).
Chatterjee, et al., Hybridoma 1:369-377 (1982).
Depper et al., Official Journal of the American Rheumatism Association Section of the Arthritis Foundation 26(4):S38 (1983).
Depper et al., Cellular Immunology 70:381 (1982).
Takahashi et al. (1983) The Lancet pp. 1155-1158.
Williams et al. (1984) J. Immunol. 132 (5), 2330.
Kirkman et al. (1983) Transplantation 36 (6), 620.
Zubler, et al. (1984) J. Exp. Med. 160 (4), 1170.
Leonard, et al. (1982) Nature 300, 267.
FitzGerald, et al. (1984) J. Clin. Invest. 74, 966.
Cotner, et al. (1983) Journal of Experimental Medicine 157 461-472.
Knox, R., "Researchers find new way to stop organ rejection," Boston Globe, May 5, 1985, p. 20.
Kelley, V.E., et al., J. Immunol. 140:59-61 (1988).
Lorberboum--Galski, H., et al. , Proc. Natl. Acad. Sci. USA 86:1008-12 (1989).
Kirkman et al., Transplantation 40(6):719-22 (1985).
Fahey, et al., Annals of Internal Med. 106:257-74 (1987).
Case, et al., PNSA USA 86:287-91 (1989).
Decker, et al., Ann. Int. Med. 101:810-24 (1984).
Powers, et al., Ann. Rev. Med. 36:533-44 (1985).
Prud'homme, et al., Diabetes 33:801-03 (1984).
Rossini, et al., Diabetes 33:543-47 91984).
Hofman et al., J. Immunol. 136:3239-45 (1986).
Fleischer et al., J. Neuroimmunol. 7:151-62 (1984).
Kronke et al., Blood 65(6):1416-1421 (1985).
Shimizu et al., Cell Structure and Function, 9, 1984, pp. 203-212.
Vallera et al., Science 222:512-515 (1983).
Strong et al., Blood 66(3):627-635 (1985).
Waldmann, "The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant Lymphocytes," Science 232:727-732 (1986).
Olsnes, et al., Pharmacol. Ther. 15:355-381 (1981).
Sewell, et al., Arthrit. & Rheum. 36(9):1223-1233 (1993).
Gottlieb, et al., (Nature Medicine) 1(5):1442-1447 (1995).
Stenmark, et al., J. Cell Biol. 113(5):1025-1032 (1991).
Kirkman, et al., J. Exp. Med. 162(1):358-362 (1985).
Gaulton, et al., Clin. Immunol. Immunopathol. 36(1):18-29 (1985).
Federation Proceedings, vol. 44(4), 1681, Abstract No. 7430, Mar., 1985.
Clinical Research, vol. 33(2), 561A, Apr., 1985.
Federation Proceedings, 44(6), 1881, Abstract No. 8589, Mar. 1985.
Bellamy, et al., Clin.. Exp. Immunol. 61(2):248-256, Aug. 1985.
Howard, et al., Transplantation Proceedings, 13(1):473-474 (1981).
Uchiyama, et al., J. Immunol. 126(4):1393-1397 (1981).
Cantrell, et al., J. Exp. Med. 158:1895-1911 (1983).
Heidecke, et al., J. Immunol. 133(2):582-588 (1984).
Reem, et al., Science 225:429-430 (1984).
Cantrell, et al., Science 224:1312-1316 (1984).
Najarian, et al., Ann. Surg. 184:352-368 (1976).
Waldmann, Annu. Rev. Biochem. 58:875-911 (1989).
Brostoff et al., J. Immunol. 133(4):1938-1942 (1984).
Waldor et al., Science 227:415-417 (1985).
Biosis Abs. No. 29034113.

Affiliated with

Also associated with

Rating

Use of interleukin-2 (IL-2) receptor-specific agents to treat al does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of interleukin-2 (IL-2) receptor-specific agents to treat al, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of interleukin-2 (IL-2) receptor-specific agents to treat al will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1373771